XBiotech (XBIT)
NASDAQ:XBIT
Want to see XBIT full AI Analyst Report?
Vilamakitug, Natrunix
Ankylosing Spondylitis, Axial Spondyloarthritis, R-Axspa, Nr-Axspa
Phase II
Not Yet Recruiting
Vilamakitug in Spondyloarthritis Placebo-controlled Investigation for Efficacy
Jun 15, 2024
―
Natrunix
Rheumatoid Arthritis
Phase II
Completed
Natrunix or Placebo in Combination With Methotrexate in Rheumatoid Arthritis
May 02, 2022
―
514G3 Plus Standard Iv Antibiotic Treatment, 514G3 Plus Standard Iv Antibiotic Treatment: Phase Ii
Staphylococcus Aureus Bacteremia
Phase I/II
Completed
Safety & Efficacy of True Human Antibody, 514G3, in Staphylococcus Aureus Bacteremia Hospitalized Subjects.
Jan 29, 2015
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does XBiotech (XBIT) have in its pipeline
XBIT is currently developing the following drugs: Methotrexate, Natrunix 400 Mg, Vilamakitug, Natrunix, Natrunix. These drug candidates are in various stages of clinical development as the company works toward FDA approval.